Alnylam Pharmaceuticals
ALNY
#619
Rank
ยฃ31.28 B
Marketcap
ยฃ234.29
Share price
3.68%
Change (1 day)
-1.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company